Abstract
A concise, nine-step enantioselective total synthesis of metacycloprodigiosin is reported. The synthesis provides increased step-efficiency over the previous racemic and enantioselective syntheses of this compound. Key features of the work include investigations into a convergent oxidative coupling reaction and subsequent ring-closing metathesis to deliver an advanced pyrrole intermediate we name the “Wasserman pyrrole” that can be converted to metacycloprodigiosin in one step.
Keywords: Prodigiosin alkaloids, Metacycloprodigiosin, Oxidative coupling, Ring-closing metathesis
The prodigiosin alkaloids (Figure 1) have attracted significant attention from the scientific community due to their unique structures, interesting biosynthesis, and biological activity.1 This potent combination of attributes has led to numerous research programs aimed at devising efficient routes to their total synthesis,2 and also spawned a successful medicinal chemistry program at Gemin X.3 Amongst the prodigiosin family, metacycloprodigiosin (1), along with streptorubin B (2), occupies a special position due to its highly strained pyrrolophane structure4 and unusual biosynthesis.5
Figure 1.
Characteristic prodigiosin alkaloids.
Isolated from Streptomyces longisporus ruber (strain M-3), the structure of metacycloprodigiosin (1) was first reported by Wasserman and coworkers in 1969.4 In the following journal article, they also reported the first total synthesis of racemic metacycloprodigiosin (1) by a 14-step route that involved the late-stage union of pyrrole 5 (i.e., the “Wasserman pyrrole”) with bis-pyrrole aldehyde 6.6 Fürstner and his group reported the second synthesis of the racemate via 5 in a formal sense in 1998 (10-steps), and again in 1999 (20-steps, also via 5).7
In 2009, our own group completed the first enantioselective synthesis of metacycloprodigiosin (1), which ultimately enabled the absolute configuration of the natural product to be assigned some 40 years after its initial structure determination.8 Our synthesis targeted pyrrole 7 as a key late-stage intermediate, which could be formed in seven steps from simple starting materials. Conversion of 7 into the target molecule required five additional steps, however, which greatly reduced the overall efficiency of our route. The methyl substituent on the pyrrole within 7, which was required for an earlier oxidative coupling reaction,9 meant that we could not utilize the same convergent coupling that Wasserman reported for pyrrole 5. While we were pleased that our route delivered metacycloprodigiosin (1) and was flexible enough to also produce the related natural product, prodigiosin R1, we wished to devise a route that would be shorter than the current 13-step synthesis. Herein we report the development of a new enantioselective synthesis of metacycloprodigiosin (1) that proceeds via enantioenriched “Wasserman pyrrole” 5 in just nine total steps.
Our first approach to a new synthesis of 1 commenced with the preparation of enoate 9 in 85% yield by the oxidation of terminal alcohol 8 followed by a Wittig olefination (Figure 3). A Feringa asymmetric addition10 of ethylmagnesium bromide gave rise to ester 10 in 69% yield and with good levels of stereoselectivity (94:6 er).11 Exhaustive reduction of the ester 10 to the corresponding alcohol with lithium aluminum hydride (LiAlH4), followed by a Parikh–Doering oxidation12 afforded the desired aldehyde 11 (80% over two steps). We next sought to prepare 1,4-dicarbonyl 11 by way of an oxidative cross-coupling reaction of aldehyde 11 with the silyl enol ether 12. In 1992, Narasaka and coworkers had reported the selective oxidative cross-coupling of silyl enol ethers with preformed enamines derived from morpholine or pyrrolidine.13 Subsequent contributions by the MacMillan lab substantially enhanced the utility of this process by rendering the transformation enantioselective through the use of enamine catalysis.14 Attempts at conducting the oxidative cross-coupling using a Narasaka-type protocol involving the initial stoichiometric generation of an enamine from aldehyde 11 with pyrrolidine or morpholine were unsuccessful, so we turned to MacMillan's conditions. After considerable experimentation we found that imidazolidinone rac-13 provided the greatest yield of the desired 1,4-dicarbonyl adduct 14. Thus, treatment of aldehyde 11 with 0.5 equivalents of 13 in the presence of 2.0 equivalents of enol silane 12 and 2.0 equivalents of ceric ammonium nitrate (CAN) provided coupled product 14 in 75% yield. Attempts to use lower loadings of 13 led to diminished yields of 14, while use of either individual enantiomer of 13 was found to have no appreciable impact on the reaction outcome.
Figure 3. Initial, unsuccessful route to metacycloprodigiosin (1).
The gratification that the efficiency of this oxidative coupling gave us was soon extinguished when we began to explore the subsequent formation of the desired 12-membered ring using ring-closing metathesis. We were initially encouraged when exposure of 14 to Grubbs II catalyst15 produced a compound whose 1H NMR spectrum displayed peaks in line with the desired enone 15. Reduction of this putative structure over Pd/C and subsequent exposure to ammonium acetate (NH4OAc) gave rise to a material whose NMR spectra were different from those reported for the Wasserman pyrrole 5.4,6,7 Most puzzling was the missing diagnostic signal at −1.88 ppm in the 1H NMR spectrum of our isolated material, which within 5 is attributed to an anisotropic shielding of the saturated hydrocarbon ring by the meta-fused pyrrole. This analysis, in conjunction with mass spectral data, led us to conclude that the ring-closing metathesis of 14 was probably generating dimeric structures instead of the more strained 12-membered ring.
Failure of this initially promising route led us to consider an alternative approach with a modified set of precursors (Figure 4). In this new approach, the alkene formed during 12-membered ring formation would be two carbon atoms removed from the ketone in much the same fashion as in our published first generation synthesis. Synthesis of the requisite homologous aldehyde 19 proceeded in a similar fashion to that developed for 11, although the use of diisobutylaluminum hydride (DIBAL) to directly reduce ester 18 to the aldehyde allowed for an increased step-efficiency. Thus, aldehyde 19 was obtained in 96:4 er over four steps from commercially available diol 16.11 Frustratingly, oxidative coupling of aldehyde 19 with enol silane 20 led to lower yields of the desired 1,4-dicarbonyl 21 than had been obtained in our initial route. Under our best set of conditions, which used a full equivalent of imidazolidinone 13, a 22% isolated yield of 1,4-dicarbonyl 21 was obtained. Control experiments using aldehyde 11 and enol silane 20, which gave rise to 62% yield of the corresponding adduct (not shown), indicated that the issue with this reaction most likely lay with the structure of the aldehyde.16 As we found for aldehyde 11, use of either enantiomer of imidazolidinone 13 rather than the racemate also provided no enhancement in yield. Despite this setback, the reaction could be conducted on sufficient scale to provide material for advancement of our synthesis and to test the now even more critical ring-closing metathesis reaction.
Figure 4. Concise route to metacycloprodigiosin (1).
Unlike 1,4-dicarbonyl 14, which did not participate in the desired ring-closure to generate the target 12-membered ring, homologous aldehyde 21 underwent ring-closing metathesis using 10 mol% of Grubbs catalyst to allow isolation of 22 in 50% yield. Hydrogenation followed by condensation with ammonium acetate (NH4OAc) yielded pyrrole (R)-5, which possessed identical NMR spectral characteristics to the “Wasserman pyrrole” including the key upfield resonance at −1.88 ppm. Wasserman and coworkers had reported the synthesis of metacycloprodigiosin (1) from 5 by condensation with bis-pyrrole aldehyde 6 (see Figure 2),5 but recent synthetic investigations have demonstrated that improved variations of this coupling can be achieved using the Boc-protected derivative 23.17 Thus, the conclusion of our synthesis was met with the HCl-mediated union of pyrrole (R)-5 with aldehyde 23, followed by the addition of sodium methoxide to cleave the Boc-group. In this way, (R)-metacycloprodigiosin (1) was produced in 68% isolated yield and shown to possess identical properties (1H NMR, 13C NMR, IR, CD) to those reported for the natural product.4,8a
Figure 2.
Key pyrrole species in previous syntheses of 1.
In conclusion, we have executed a short, nine-step enantioselective total synthesis of (R)-metacycloprodigiosin (1) that takes advantage of the convergent late-stage union of a bis-pyrrole aldehyde (i.e., 23) with an optically enriched meta-fused macrocyclic pyrrole (i.e., the “Wasserman pyrrole” (R)-5). An initially promising, yet ultimately unsuccessful, route highlights the challenges associated with ring-closing metathesis approaches for generating strained medium-sized rings. By utilizing an isomeric species with the terminal alkenes located in different positions, this challenge of ring-closure was overcome and a successful synthesis achieved. Ultimately, this new route has improved the step-count for the enantioselective synthesis of metacycloprodigiosin from 13-steps to 9-steps.
Supplementary Material
Acknowledgments
This work was supported by Northwestern University and the National Institutes of Health (1R01GM085322).
Footnotes
Supplementary Material: Experimental procedures and spectral data for all new compounds.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.For general reviews of the chemistry and biology of the prodigiosins, see: Fürstner A. Angew Chem Int Ed. 2003;42:3582–3603. doi: 10.1002/anie.200300582.Williamson NR, Fineran PC, Leeper FJ, Salmond GPC. Nat Rev Microbiol. 2006;4:887–899. doi: 10.1038/nrmicro1531.Williamson NR, Fineran PC, Gristwood T, Chawrai SR, Leeper FJ, Salmond GPC. Future Microbiol. 2007;2:605–618. doi: 10.2217/17460913.2.6.605.
- 2.Rapoport H, Holden KG. J Am Chem Soc. 1962;84:635–642.Wasserman HH, Fukuyama JM. Tetrahedron Lett. 1984;25:1387–1388.Boger DL, Patel M. J Org Chem. 1988;53:1405–1415.Wasserman HH, Lombardo LJ. Tetrahedron Lett. 1989;30:1725–1728.D'Alessio R, Rossi A. Synlett. 1996:513–514.Fürstner A, Jaroslaw G, Lehmann CW. J Org Chem. 1999;64:8275–8280. doi: 10.1021/jo991021i.Fürstner A, Radkowski K, Peters H. Angew Chem. 2005;44:2777–2781. doi: 10.1002/anie.200462215.Reeves JT. Org Lett. 2007;9:1879–1881. doi: 10.1021/ol070341i.Schultz EE, Sarpong R. J Am Chem Soc. 2013;135:4696–4699. doi: 10.1021/ja401380d.Jones BT, Hu DX, Savoie BM, Thomson RJ. J Nat Prod. 2013;76:1937–1945. doi: 10.1021/np400531b. See also, ref. 6,7 and 8.
- 3.O'Brien SM, Claxton DF, Crump M, Faderi S, Kipps T, Keating MJ, Viallet J, Cheson BD. Blood. 2009;113:299–305. doi: 10.1182/blood-2008-02-137943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.(a) Wasserman HH, Rodgers GC, Keith DD. J Am Chem Soc. 1969;91:1263–1264. doi: 10.1021/ja01033a065. [DOI] [PubMed] [Google Scholar]; (b) Wasserman HH, Keith DD, Rodgers GC. Tetrahedron. 1976;32:1855–1861. [Google Scholar]
- 5.Sydor PK, Barry SM, Odulate OM, Barona-Gomez F, Haynes SW, Corre C, Song L, Challis GL. Nat Chem. 2011;3:388–392. doi: 10.1038/nchem.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.(a) Wasserman HH, Keith DD, Nadelson J. J Am Chem Soc. 1969;91:1264–1265. doi: 10.1021/ja01033a066. [DOI] [PubMed] [Google Scholar]; (b) Wasserman HH, Keith DD, Nadelson J. Tetrahedron. 1976;32:1867–1871. [Google Scholar]
- 7.(a) Fürstner A, Szillat H, Gabor B, Mynott R. J Am Chem Soc. 1998;120:8305–8314. [Google Scholar]; (b) Fürstner A, Krause H. J Org Chem. 1999;64:8281–8286. doi: 10.1021/jo991022a. [DOI] [PubMed] [Google Scholar]
- 8.(a) Clift MD, Thomson RJ. J Am Chem Soc. 2009;131:14579–14583. doi: 10.1021/ja906122g. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Hu DH, Clift MD, Lazarski KE, Thomson RJ. J Am Chem Soc. 2011;133:1799–1804. doi: 10.1021/ja109165f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Guo F, Clift MD, Thomson RJ. Eur J Org Chem. 2012;26:4881–4896. doi: 10.1002/ejoc.201200665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Howell GP, Fletcher SP, Geurts K, ter Horst B, Feringa BL. J Am Chem Soc. 2006;128:14977–14985. doi: 10.1021/ja0651862. [DOI] [PubMed] [Google Scholar]
- 11.See Supporting Information for details regarding enantiomeric ratio determination.
- 12.Parikh JR, Doering WvE. J Am Chem Soc. 1967;89:5505–5507. [Google Scholar]
- 13.Narasaka K, Okauchi T, Tanaka K, Murakami M. Chem Lett. 1992:2099–2102. [Google Scholar]
- 14.(a) Jang HY, Hong JB, MacMillan DWC. J Am Chem Soc. 2007;129:7004–7005. doi: 10.1021/ja0719428. [DOI] [PubMed] [Google Scholar]; (b) Beeson TD, Mastracchio A, Hong JB, Ashton K, MacMillan DWC. Science. 2007;316:582–585. [PubMed] [Google Scholar]
- 15.Scholl M, Ding S, Lee CW, Grubbs RH. Org Lett. 1999;1:953–956. doi: 10.1021/ol990909q. [DOI] [PubMed] [Google Scholar]
- 16.Intramolecular cyclization onto the terminal alkene within 19 is the most likely reason for the ineffectiveness of this particular substrate. See ref. 14 for examples.
- 17.Aldrich LN, Dawson ES, Lindsley CW. Org Lett. 2010;12:1048–1051. doi: 10.1021/ol100034p. For additional examples, see: ref. 2i, 2j, and 8b.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




